Rainer Kufer
Goeppingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker.
Journal: Urologic oncology
Published: December 20, 2021
Functional Outcome and Complications following Ileal Neobladder Reconstruction in Male Patients without Tumor Recurrence. More than 35 Years of Experience from a Single Center.
Journal: The Journal of urology
Published: August 29, 2020
Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer.
Journal: International journal of cancer
Published: February 15, 2019
TRIM24 as an independent prognostic biomarker for prostate cancer.
Journal: Urologic oncology
Published: February 13, 2019
Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis.
Journal: Frontiers in oncology
Published: October 08, 2018
Retraction Note to: Histopathology reports of findings of prostate needle biopsies
Journal: Der Urologe. Ausg. A
Published: August 30, 2017
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups.
Journal: Frontiers in medicine
Published: May 27, 2017
Genetic Variants of DICE1/INTS6 in German Prostate Cancer Families with Linkage to 13q14.
Journal: Urologia internationalis
Published: June 24, 2014
Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: June 13, 2013
Frequent truncating mutations of STAG2 in bladder cancer.
Journal: Nature genetics
Published: March 19, 2013
Last Updated: 09/26/2026